Acute kidney injury after ruxolitinib: Common complication, uncommon cause

Am J Hematol. 2020 Jul;95(7):E181-E183. doi: 10.1002/ajh.25804. Epub 2020 Apr 17.

Authors

Samuel Strohbehn¹, Harish Seethapathy¹, Nifasha Rusibamayila¹, Ian Strohbehn², Meghan Lee², Gabriela Hobbs³, Alla Keyzner⁴, Kenar D Jhaveri⁵, Meghan E Sise¹

Affiliations

¹ Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
⁴ Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
⁵ Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

No abstract available

Publication types

Letter

MeSH terms

Acute Kidney Injury* / chemically induced
Acute Kidney Injury* / epidemiology
Acute Kidney Injury* / pathology
Adult
Aged
Female
Graft vs Host Disease* / drug therapy
Graft vs Host Disease* / epidemiology
Graft vs Host Disease* / pathology
Hematologic Neoplasms* / drug therapy
Hematologic Neoplasms* / epidemiology
Humans
Male
Middle Aged
Nitriles
Pyrazoles* / administration & dosage
Pyrazoles* / adverse effects
Pyrimidines
Retrospective Studies

Substances

Nitriles
Pyrazoles
Pyrimidines
ruxolitinib

Grants and funding

K23 DK117014/DK/NIDDK NIH HHS/United States